News & Events
-
Public Calendar: September 5-9, 2011
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
| September 5-9, 2011 | |||||
| FDA Official and Title | Date | Location | Other FDA Participants | Non-FDA Participants | Subject |
|---|---|---|---|---|---|
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 9/7/11 | New York, NY | N/A | Marc Tessier-Lavigne (Rockefeller University) | FDA and Regulatory Science |
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 9/8/11 | New York, NY | N/A | N/A | Keynote: Reducing Risk through Effective Policy and Public Health Practice |
| John M. Taylor, III, J.D., Counselor to the Commissioner | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy | 9/6/11 | Silver Spring, MD | Dara Corrigan, David Elder, Domenic Veneziano, Roberta Wagner | Cheryl Becker (DHL); Robby Beau, Andy Shiles, Tom Parker (FedEx); Don Woods (UPS); Mike Mullen (Express Association of America) | FDA's Oversight of Import Entries Involving Express Courier Operations |
| Dara A. Corrigan, Associate Commissioner for Regulatory Affairs | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Lawrence R. Deyton, MSPH, MD, Director, Center for Tobacco Products | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Virginia Cox, Associate Commissioner for External Affairs | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Elizabeth H. Dickinson, Esq., Acting Chief Counsel | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Caroline Lewis, Associate Commissioner for Operations | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research | 9/6/11 | Little Rock, AR | N/A | Daniel Rahn (University of Arkansas for Medical Sciences) | Implementation of MOU between FDA and the State of Arkansas |
| Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs | 9/5/11-9/9/11 | N/A | N/A | N/A | No Significant Meetings |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 9/8/11 | Rockville, MD | Scott Furness, Larry Ouderkirk | Roger Williams, Matthew Van Hook (U.S. Pharmacopeia) | Over the Counter Drug Substances and Products |
-
-
